- Home
- BHAT vs SNSE Comparison
BHAT vs SNSE Comparison
Compare BHAT & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHAT
- SNSE
- Stock Information
- Founded
- BHAT 2010
- SNSE 2005
- Country
- BHAT China
- SNSE United States
- Employees
- BHAT N/A
- SNSE N/A
- Industry
- BHAT Recreational Games/Products/Toys
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- BHAT Consumer Discretionary
- SNSE Health Care
- Exchange
- BHAT Nasdaq
- SNSE Nasdaq
- Market Cap
- BHAT 14.5M
- SNSE 12.3M
- IPO Year
- BHAT 2019
- SNSE 2021
- Fundamental
- Price
- BHAT $0.19
- SNSE $0.46
- Analyst Decision
- BHAT
- SNSE Strong Buy
- Analyst Count
- BHAT 0
- SNSE 3
- Target Price
- BHAT N/A
- SNSE $4.33
- AVG Volume (30 Days)
- BHAT 431.4K
- SNSE 894.4K
- Earning Date
- BHAT 12-20-2024
- SNSE 11-14-2024
- Dividend Yield
- BHAT N/A
- SNSE N/A
- EPS Growth
- BHAT N/A
- SNSE N/A
- EPS
- BHAT N/A
- SNSE N/A
- Revenue
- BHAT $73,686,733.00
- SNSE N/A
- Revenue This Year
- BHAT N/A
- SNSE N/A
- Revenue Next Year
- BHAT N/A
- SNSE N/A
- P/E Ratio
- BHAT N/A
- SNSE N/A
- Revenue Growth
- BHAT 3255.57
- SNSE N/A
- 52 Week Low
- BHAT $0.17
- SNSE $0.38
- 52 Week High
- BHAT $1.45
- SNSE $1.94
- Technical
- Relative Strength Index (RSI)
- BHAT 32.17
- SNSE 43.28
- Support Level
- BHAT $0.17
- SNSE $0.52
- Resistance Level
- BHAT $0.24
- SNSE $0.59
- Average True Range (ATR)
- BHAT 0.03
- SNSE 0.05
- MACD
- BHAT -0.00
- SNSE -0.01
- Stochastic Oscillator
- BHAT 19.57
- SNSE 8.72
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is a producer, developer, and operator of augmented reality (AR) interactive entertainment games and toys in China, including interactive educational materials, mobile games, and toys with mobile game features. The company's products include AR Racer, AR Crazy Bug, AR 3D Magic Box, AR Dinosaur, Talking Tom and Friends Bouncing Bubble, and Immersive Education Classes. The company reports in the following segments: Interactive toys - animation series, Interactive toys - game series, and Mobile games, Information services, and Communication services, out of which the majority of the revenue is generated from the game series. The majority of its revenues are generated in China.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.